Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cyclophosphamide-induced ovarian failure.

× No keyword cloud information.

60 in total

1. Adjunctive GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients.

Authors: W Marder; W J McCune; L Wang; J J Wing; S Fisseha; D S McConnell; G M Christman; E C Somers
Journal: Gynecol Endocrinol Date: 2012-02-02 Impact factor: 2.260

2. Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients.

Authors: Yee Chung Cheng; Mariko Takagi; Andrea Milbourne; Richard E Champlin; Naoto T Ueno
Journal: Oncologist Date: 2012-01-26

3. Association of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors.

Authors: H Irene Su; Mary D Sammel; Luke Velders; Michelle Horn; Corrie Stankiewicz; Jennifer Matro; Clarisa R Gracia; Jamie Green; Angela DeMichele
Journal: Fertil Steril Date: 2009-04-18 Impact factor: 7.329

Review 4. The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage.

Authors: Alexander Rühle; Ramon Lopez Perez; Bingwen Zou; Anca-Ligia Grosu; Peter E Huber; Nils H Nicolay
Journal: Stem Cell Rev Rep Date: 2019-06 Impact factor: 5.739

5. Premature ovarian failure.

Authors: R Jewelewicz; M Schwartz
Journal: Bull N Y Acad Med Date: 1986-04

Review 6. Challenges and Potential for Ovarian Preservation with SERMs.

Authors: Alison Y Ting; Brian K Petroff
Journal: Biol Reprod Date: 2015-03-25 Impact factor: 4.285

7. Cadmium Exposure and Ovarian Reserve in Women Aged 35-49 Years: The Impact on Results From the Creatinine Adjustment Approach Used to Correct for Urinary Dilution.

Authors: Kristen Upson; Katie M O'Brien; Janet E Hall; Erik J Tokar; Donna D Baird
Journal: Am J Epidemiol Date: 2021-01-04 Impact factor: 4.897

Cyclophosphamide-induced ovarian failure.